Next Investors logo grey

High value applications for Archer’s graphite


Published 23-JUL-2018 12:11 P.M.


3 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

Archer Exploration Limited (ASX:AXE) has announced results of the independent collaborations between AXE and The University of Adelaide and Flex-G Pty. Ltd (FlexeGRAPH) regarding the preparation of graphene-based material products from its Campoona graphite deposit.

AXE along with The University of Adelaide and FlexeGRAPH has showed a number of different processes can be utilised for the Campoona graphite to produce graphene and graphene-based products. This was demonstrated by preparing the graphene materials using a number of different approaches, including publicly available and proprietary methods.

The University of Adelaide prepared graphene materials from AXE’s Campoona graphite, which included graphene powder and graphene oxide, using established, publicly available chemical and mechanical exfoliation processes.

FlexeGRAPH prepared a water-based graphene material dispersion using proprietary methodology involving surfactant assisted exfoliation.

AXE undertook technical analysis to verify that the graphene materials, properties, and quality at the world-class Australian Centre for Microscopy & Microanalysis at The University of Sydney and The University of New South Wales Mark Wainwright Analytical Centre.

The results of the technical analysis confirmed that the graphite from the Campoona deposit could be used to produce multiple graphene-based products from a number of different methods. This is critical for value-add applications and high-quality graphene production using graphitic feedstocks in the targeted areas of reliable energy, human health, and quantum technology.

The graphene materials were produced with high yields, purity, and scaleup potential suitable for use in reliable energy, human health, and quantum technology applications.

This is significant as graphene powders, dispersions, and graphene oxide products prepared to target major segments in the graphene technology market, which is expected to grow to US$70 billion by 2030.

It should be noted, however, that this is an early stage company and success is no guarantee. Investors should seek professional financial advice before making an investment.

Archer CEO Dr Mohammad Choucair commented, “We are confident in our capability to provide high-quality graphite that is process agnostic in the production of graphene. Regardless of avenue taken, our Campoona graphite resulted in graphene materials that demonstrate the structural integrity suitable for high value applications.

“The work with The University of Adelaide and FlexeGRAPH highlights our continued and successful collaborative efforts, and provides Archer with commercial opportunities to develop high-value graphene integration solutions in an emerging and growing graphene materials market.”

The results of the work will now be used to commercially translate products in areas relating to high volume and high value graphite-to-graphene development.

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.